CN106946770B - High-activity imido phenylacetate compound and preparation method and application thereof - Google Patents

High-activity imido phenylacetate compound and preparation method and application thereof Download PDF

Info

Publication number
CN106946770B
CN106946770B CN201710160407.4A CN201710160407A CN106946770B CN 106946770 B CN106946770 B CN 106946770B CN 201710160407 A CN201710160407 A CN 201710160407A CN 106946770 B CN106946770 B CN 106946770B
Authority
CN
China
Prior art keywords
compound
imido
acid ester
compound shown
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201710160407.4A
Other languages
Chinese (zh)
Other versions
CN106946770A (en
Inventor
覃兆海
杨冬燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Agricultural University
Original Assignee
China Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Agricultural University filed Critical China Agricultural University
Priority to CN201710160407.4A priority Critical patent/CN106946770B/en
Publication of CN106946770A publication Critical patent/CN106946770A/en
Application granted granted Critical
Publication of CN106946770B publication Critical patent/CN106946770B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • C07D213/6432-Phenoxypyridines; Derivatives thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/12Powders or granules
    • A01N25/14Powders or granules wettable
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/10Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
    • A01N47/24Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing the groups, or; Thio analogues thereof

Abstract

The invention belongs to the field of pesticides, and particularly relates to a high-activity imido phenylacetate compound, and a preparation method and application thereof. The invention aims at the research of novel methoxy acrylate compounds, introduces a pyridine aryl ether structure in the structure, widens the research on the structure of the novel compounds, and discovers the high-activity imido phenylacetate compounds. The compound shows biological activity equivalent to that of azoxystrobin and trifloxystrobin, has better effect on most pathogenic bacteria, has outstanding effect on preventing and treating sclerotinia sclerotiorum, and still has effect under low dosage.

Description

High-activity imido phenylacetate compound and preparation method and application thereof
Technical Field
The invention belongs to the field of pesticides, and particularly relates to a high-activity imido phenylacetate compound, and a preparation method and application thereof.
Background
The Strobilurin fungicide is an important fungicide successfully developed by taking a natural product Strobilurin A as a lead compound, has the characteristics of high efficiency, low toxicity, broad spectrum and systemic property, and has the functions of protection, treatment and eradication. The strobilurin fungicide has good activity on almost all fungal diseases such as basidiomycetes, ascomycetes, deuteromycetes and oomycetes, and can prevent and treat rust disease, powdery mildew, downy mildew, rice blast and other diseases of various crops. The strobilurin fungicide is a mitochondrial respiratory chain inhibitor, and is used for inhibiting cytochrome b and c1The electron transfer between the two can prevent the synthesis of cell energy, and further inhibit the mitochondrial respiration, thereby achieving the bacteriostatic action. The characteristics of unique action mechanism, high efficiency, broad spectrum and environmental friendliness make the strobilurin fungicide become an agricultural fungicide variety with high market activity and development potential and also become a research hotspot in the pesticide field.
Almost all large pesticide companies are involved in the development of such compounds. The new compounds with high activity are mainly developed by Shenyang chemical research institute, Zhejiang chemical research institute and other organizations in China, the research of other organizations mainly aims at the compounding of commercialized products, the research of compound compositions tends to be mature, but the research and development of the compounds are still deficient in China, and the development of innovative compounds with high activity is much less and less. In addition, the long-term large-scale unreasonable use of the methoxy acrylic ester bactericide is easy to cause drug resistance of pathogenic bacteria, and the pathogenic bacteria are not sensitive to the bactericide to cause the loss of the drug effect.
Disclosure of Invention
The invention aims to provide a high-activity imido phenylacetate compound and a preparation method and application thereof, and the specific technical scheme is as follows:
the high-activity imido phenylacetic acid ester compound is a compound shown in a formula I,
Figure BDA0001248347480000021
in the formula I, R1、R2、R3、R4And R5Respectively hydrogen, halogen, nitro, cyano, hydroxyl, amino, substituted amino, acetamido, methyl ketone, substituted oxime benzyl ether and C1-C12Alkyl, halo C1-C12Alkyl radical, C1-C12Alkoxy radical, C1-C12Alkylthio radical, C1-C12Alkanesulfonyl group, C1-C12Alkylcarbonyl, benzyloxy, or aryloxy.
The aryloxy group is phenoxy and pyridyloxy.
The preparation method of the high-activity imido phenylacetic acid ester compound comprises the following steps:
1) diethyl malonate reacts with magnesium chloride to obtain diethyl carboxylic acid methyl magnesium chloride, chloronicotinic acid reacts with thionyl chloride to obtain chloronicotinoyl chloride, the diethyl carboxylic acid methyl magnesium chloride reacts with the chloronicotinoyl chloride to obtain a compound shown in a structural formula 1, the compound shown in the structural formula 1 is decomposed by a ketone formula to obtain a compound shown in a structural formula 2, and then the compound is reacted with polysubstituted phenol to obtain a compound shown in an intermediate 1;
2) preparing a compound shown in a structural formula 4 by taking N-hydroxyphthalimide and a compound shown in a structural formula 3 as raw materials, and then reacting the compound with hydrazine hydrate to obtain a compound shown in an intermediate 2;
3) and reacting the intermediate 1 with the intermediate 2 to obtain the compound shown in the formula I.
Figure BDA0001248347480000022
Figure BDA0001248347480000031
The application of the high-activity imino phenylacetic acid ester compound in preparing a bactericide.
The active component of the bactericide is the high-activity imino phenylacetic ester compound.
The wettable bactericide powder consists of the following substances in percentage by mass: 40% of the high-activity imino phenylacetic acid ester compound in claim 1, 2% of sodium dodecyl sulfate, 3% of sodium lignosulfonate, 5% of naphthalene sulfonic acid formaldehyde condensate and 50% of light calcium carbonate.
A bactericide suspending agent comprises the following substances in percentage by mass: 50% of the high-activity imido phenylacetic acid ester compound disclosed in claim 1, 10% of ethylene glycol, 6% of nonylphenol polyethylene glycol ether, 10% of sodium lignosulfonate, 1% of carboxymethyl cellulose, 0.2% of aqueous formaldehyde solution with the mass fraction of 37%, 0.8% of aqueous silicone oil emulsion with the mass fraction of 75% and 22% of water.
The bactericide water dispersible granule consists of the following substances in percentage by mass: 45% of the high-activity imino phenylacetic acid ester compound in claim 1, 12% of naphthalene sulfonic acid formaldehyde condensate, 8% of N-methyl-N-oleoyl-sodium taurate, 2% of polyvinylpyrrolidone and 3% of kaolin.
The bactericide composition consists of the following substances in percentage by mass: 20% of the high-activity imino phenylacetic acid ester compound of claim 1, 20% of pyraclostrobin, 20% of dispersant, 0-1% of organic bentonite, 1-5% of polyethylene glycol PEG2000 and 34% -39% of water.
The invention has the beneficial effects that:
the invention aims at the research of novel methoxy acrylate compounds, introduces a pyridine aryl ether structure in the structure, widens the research of the structure of the novel compounds, and discovers a novel methoxy acrylate compound with high activity: imido phenylacetic acid ester compounds. The compound shows biological activity equivalent to that of azoxystrobin and trifloxystrobin, has better effect on most pathogenic bacteria, has outstanding effect on preventing and treating sclerotinia sclerotiorum, and still has effect under low dosage.
Detailed Description
The invention provides a high-activity imido phenylacetate compound, a preparation method and application thereof, and the invention is further described by combining with an embodiment.
In the compounds of the formula I according to the invention R1、R2、R3、R4And R5The substituents are exemplified by, but not limited to, table 1.
In the compound of formula I R1、R2、R3、R4And R5Substituent group
Figure BDA0001248347480000041
Figure BDA0001248347480000051
Figure BDA0001248347480000061
Figure BDA0001248347480000071
The synthesis route of the imido phenylacetic acid ester compound containing the aryloxypicoline oxime ether structural unit provided by the invention is as follows:
Figure BDA0001248347480000072
the reaction is carried out in a suitable solvent, such as tetrahydrofuran, acetonitrile, toluene, xylene, benzene, N-dimethylformamide, dimethyl sulfoxide, acetone, methanol, and the like.
Suitable acids may be selected from acetic acid, hydrochloric acid, nitric acid, sulfuric acid, methanesulfonic acid, p-toluenesulfonic acid, formic acid, phosphoric acid, and the like.
The reaction temperature is between ice bath and room temperature, typically 0-25 ℃.
The reaction time is from 0.5h to 24h, usually 20 h.
The synthetic route of the intermediate 1 is as follows:
Figure BDA0001248347480000081
the reaction is carried out in a suitable solvent, such as tetrahydrofuran, acetonitrile, toluene, xylene, benzene, N-dimethylformamide, dimethylsulfoxide, acetone, and the like.
Suitable bases may be selected from sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate, triethylamine, pyridine, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium tert-butoxide, cesium carbonate, and the like.
Each reaction temperature is between the temperature of ice bath and the boiling point temperature of the solvent, and is usually 0-100 ℃; the reaction times are in the range from 0.5h to 20h, usually from 4 to 8 h.
The synthetic route of intermediate 2 is as follows:
Figure BDA0001248347480000082
the reaction is carried out in a suitable solvent, such as tetrahydrofuran, acetonitrile, toluene, xylene, benzene, N-dimethylformamide, dimethyl sulfoxide, acetone, methanol, and the like.
Suitable bases may be selected from sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate, triethylamine, pyridine, sodium methoxide, sodium ethoxide, potassium tert-butoxide, sodium tert-butoxide, and the like.
Each reaction temperature is between the temperature of ice bath and the boiling point temperature of the solvent, and is usually 0-100 ℃; the reaction times are in the range from 0.5h to 20h, usually from 4 to 8 h.
The experimental methods described in the following examples are all conventional methods unless otherwise specified; the reagents and materials are commercially available, unless otherwise specified.
Example 1: synthesis of Compound Ia
Figure BDA0001248347480000091
(1) Preparation of pyridine aryl ether methyl ketone (P1)
Figure BDA0001248347480000092
a) Triethylamine (183.2g, 1.8mol) and diethyl malonate (119g, 0.9mol) were charged in a 2L three-necked flask, and dried toluene (700ml) was added thereto, followed by addition of magnesium chloride (51g, 0.53mol) with stirring. The reaction was stirred at room temperature (25 ℃ C.) for 1.5 h.
b) 6-Chloronicotinic acid (120g, 0.75mol), thionyl chloride (300ml) and dry toluene (200ml) were added to a 1L three-necked flask, and two drops of DMF were added dropwise thereto, followed by heating and refluxing for 2 hours. After cooling slightly, the reflux apparatus was changed to a distillation apparatus, and excess thionyl chloride and the solvent toluene were distilled off. Immediately after completion, heating was stopped, and after cooling, the remaining toluene was evaporated by using a rotary evaporator.
c) Adding a proper amount of dry toluene into the product obtained after distillation in the step b) for dilution, and slowly adding the diluted product into the reaction liquid stirred at room temperature in the step a). Stirring was continued for 40min and then acidified with concentrated HCl solution (261g, 2.32 mol). The toluene layer was rotary evaporated and cooled to yield a pale yellow solid. To this solid was added DMSO (650ml) and water (29ml) exactly. The mixture was heated and maintained at 155 ℃ for 3h, then the heating was stopped, the reaction solution was cooled and poured into 2.5L of cold water, a large amount of off-white solid precipitated, filtered and dried. 94g of the product 6-chloro-3-acetylpyridine is obtained, and the yield is 70.1%.
d) Synthesis of pyridine aryl ether methyl ketone (P1)
A500 ml flask was charged with 6-chloro-3-acetylpyridine (18.7g, 0.12mol), p-cresol (14.26g, 0.132mol) and cesium carbonate (39g, 0.12mol), as well as DMF (300ml) solvent. Heating and refluxing, stopping heating after 1h, and cooling. The reaction solution is poured into excessive water, stirred to separate out solid, and filtered. The crude product was recrystallized from ethyl acetate. Dry, weigh 16g, light yellow crystals, 58.7% yield.
m.p.125-127℃,1H NMR,δ:2.24(s,3H)2.57(s,3H);7.00(q,1H,J=0.68Hz);7.12(m,2H,J=3.20Hz);7.40(m,2H,J=3.24Hz);8.27(dd,1H,J=2.48Hz);8.74(dd,1H,J=0.67Hz).
(2) Preparation of substituted benzyloxyamines (P2)
Figure BDA0001248347480000101
Adding a solvent DMF100ml into a 250ml three-neck flask provided with a stirrer and a condenser, adding 16.3g (0.1mol) of N-hydroxyphthalimide, heating, completely dissolving the solid, adding corresponding halogenated alkane according to the mass ratio of 1:1, slowly heating to 60 ℃, reacting for five minutes, adding triethylamine according to the mass ratio of 1:1.1, heating to 60 ℃ under stirring for reaction, detecting that the reaction is complete by a point plate, slowly cooling to room temperature, pouring ice water, precipitating the solid, filtering and drying to obtain the product N-substituted benzyloxy-phthalimide.
A250 mL single-neck flask was charged with a stirrer, 100mL of methanol as a solvent was added, and N-substituted benzyloxyphthalimide (0.1mol) was added thereto and stirred in a mass ratio of 1:1, adding hydrazine hydrate solid dropwise, dissolving completely, generating turbidity again for a moment, detecting that the raw material reaction is finished after 2h, performing suction filtration, and directly using the methanol solution of the product P2 in the next step.
(3) Synthesis of Compound Ia
A250 mL three-necked bottle is filled with a stirrer, 100mL of a methanol solution of P2 is added, the same amount of the pyridine aryl ether methyl ketone (P1) is added, a small amount of acetic acid is added, and the mixture is stirred for 24 hours at room temperature. Detecting the reaction by a point plate until the raw materials are completely reacted, separating by a column, and performing separation by using petroleum ether: ethyl acetate 10:1 as eluent, the product was isolated. Yield 76% as a white solid.
The structure confirmation data is:1H NMR(300MHz,CDCl3)δ8.40(d,J=1.9Hz,1H),8.02(dd,J=8.7,2.5Hz,1H),7.58–7.50(m,1H),7.44(dtd,J=12.7,7.3,1.7Hz,2H),7.29–7.21(m,3H),7.13–7.02(m,2H),6.90(d,J=8.7Hz,1H),5.17(s,2H),4.08(s,3H),3.87(s,3H),2.41(s,3H),2.22(s,3H).13C NMR(75MHz,CDCl3)δ164.14,162.98,151.83,151.26,149.32,145.19,136.69,135.84,134.14,129.90,129.57,129.02,128.50,128.26,127.39,126.78,120.80,110.56,74.48,63.41,52.51,20.55,11.89.HRMS(ESI)m/z calcd for C25H26N3O5(M+H)+448.1867,found 448.1871.
example 2: synthesis of Compound Ib
Figure BDA0001248347480000111
(1) Preparation of pyridine aryl ether methyl ketone (P3)
Figure BDA0001248347480000112
a) Triethylamine (183.2g, 1.8mol) and diethyl malonate (119g, 0.9mol) were charged in a 2L three-necked flask, and dried toluene (700ml) was added thereto, followed by addition of magnesium chloride (51g, 0.53mol) with stirring. The reaction was stirred at room temperature (25 ℃ C.) for 1.5 h.
b) 2-Chloronicotinic acid (120g, 0.75mol), thionyl chloride (300ml) and dry toluene (200ml) were added to a 1L three-necked flask, and two drops of DMF were added dropwise thereto, followed by heating and refluxing for 2 hours. After cooling slightly, the reflux apparatus was changed to a distillation apparatus, and excess thionyl chloride and the solvent toluene were distilled off. Immediately after completion, heating was stopped, and after cooling, the remaining toluene was evaporated by using a rotary evaporator.
c) Adding a proper amount of dry toluene into the product obtained after distillation in the step b) for dilution, and slowly adding the diluted product into the reaction liquid stirred at room temperature in the step a). Stirring was continued for 40min and then acidified with concentrated HCl solution (261g, 2.32 mol). The toluene layer was rotary evaporated and cooled to yield a pale yellow solid. To this solid was added DMSO (650ml) and water (29ml) exactly. Heating the mixture at 155 deg.C for 3h, stopping heating, cooling the reaction solution, pouring into 2.5L cold water to precipitate off-white solid, filtering, and drying. 96g of the product 2-chloro-3-acetylpyridine is obtained, and the yield is 72 percent.
d) Synthesis of pyridine aryl ether methyl ketone (P3)
A500 ml flask was charged with 2-chloro-3-acetylpyridine (18.7g, 0.12mol), o-cresol (14.26g, 0.132mol) and cesium carbonate (39g, 0.12mol), as well as DMF (300ml) solvent. Heating and refluxing, stopping heating after 1h, and cooling. The reaction solution is poured into excessive water, stirred to separate out solid, and filtered. The crude product was recrystallized from ethyl acetate. Dry, weigh 16.8g, white crystals, 62% yield.
m.p.36-37℃,1H NMR(300MHz,CDCl3)δ8.38–8.18(m,2H),7.33(dd,J=13.7,7.6Hz,2H),7.24(dt,J=7.4,3.7Hz,1H),7.11(dd,J=10.4,3.9Hz,2H),2.85(s,3H),2.25(s,3H).
(2) Preparation of substituted benzyloxyamines (P2)
Figure BDA0001248347480000121
Adding a solvent DMF100ml into a 250ml three-neck flask provided with a stirrer and a condenser, adding 16.3g (0.1mol) of N-hydroxyphthalimide, heating, completely dissolving the solid, adding corresponding halogenated alkane according to the mass ratio of 1:1, slowly heating to 60 ℃, reacting for five minutes, adding triethylamine according to the mass ratio of 1:1.1, heating to 60 ℃ under stirring for reaction, detecting that the reaction is complete by a point plate, slowly cooling to room temperature, pouring ice water, precipitating the solid, filtering and drying to obtain the product N-substituted benzyloxy-phthalimide.
A250 mL single-neck flask was charged with a stirrer, 100mL of methanol as a solvent was added, and N-substituted benzyloxyphthalimide (0.1mol) was added thereto and stirred in a mass ratio of 1:1, adding hydrazine hydrate solid dropwise, dissolving completely, generating turbidity again for a moment, detecting that the raw material reaction is finished after 2h, performing suction filtration, and directly using the methanol solution of the product P2 in the next step.
(3) Synthesis of Compound Ib
A250 mL three-necked bottle is filled with a stirrer, 100mL of a methanol solution of P2 is added, the same amount of the pyridine aryl ether methyl ketone (P3) is added, a small amount of acetic acid is added, and the mixture is stirred for 24 hours at room temperature. Detecting the reaction by a point plate until the raw materials are completely reacted, separating by a column, and performing separation by using petroleum ether: ethyl acetate 10:1 as eluent, the product was isolated. Yield 73%, oily liquid.
The structure confirmation data is:1H NMR(300MHz,CDCl3)δ8.41(d,J=1.9Hz,1H),8.02(dd,J=8.7,2.4Hz,1H),7.58–7.49(m,1H),7.49–7.35(m,2H),7.34–7.23(m,4H),7.22–7.06(m,2H),6.89(d,J=8.7Hz,1H),5.20(s,2H),4.06(s,3H),3.84(s,3H),2.22(s,6H).13C NMR(75MHz,CDCl3)δ163.82,162.95,151.84,151.79,149.35,145.28,136.81,135.90,131.07,130.36,129.69,129.01,128.53,128.33,127.41,126.84,126.62,125.07,121.59,109.99,74.53,63.34,52.43,16.04,11.85.HRMS(ESI)m/z calcd for C25H26N3O5(M+H)+448.1867,found 448.1867.
example 3: determination of biological activity of high-activity imido phenylacetate compound
The indoor bactericidal activity test of the high-activity imido phenylacetic acid ester compounds is carried out by reference to literature methods, and the specific steps are as follows:
(1) preparation of PDA Medium
PDA culture medium (1L deionized water: potato 200 g: agar 20 g: glucose 20g) preparation: cleaning potato, peeling, cutting into small pieces, weighing 1400g, wrapping with two double-layer gauzes, boiling with deionized water, adding wrapped potato, and decocting for 30 min; taking out the potatoes after 30min, slowly adding 140g of agar strips soaked by deionized water, and stirring while boiling until the agar strips are completely dissolved; and (3) completely dissolving the agar strips within about 30min, adding 140g of glucose, uniformly stirring, and adding water to a constant volume of 7L. Subpackaging with conical flask, sealing with sterile culture container, sterilizing with autoclave, maintaining at 121 deg.C for 30min, and taking out.
(2) Liquid medicine preparation
Respectively weighing 20mg of the compound to be detected, the azoxystrobin and the trifloxystrobin by using a ten-thousandth balance, adding the compound to be detected, the azoxystrobin and the trifloxystrobin into a 1ml centrifuge tube, and dissolving the mixture with 5ml DMSO for ultrasonic treatment to prepare a mother solution of 20000 mg/L; sterilizing a super clean bench for 30min, diluting the prepared mother solution into 50mg/L of culture medium with drugs by using a PDA (PDA dextrose agar) culture medium under the aseptic condition of the super clean bench, pouring into culture dishes with 15ml of each dish to obtain a flat plate with the culture medium with drugs; the experiment was set up with a blank control without agent and a DMSO solvent control, each treatment was repeated three times.
(3) Experimental methods
Sterilizing a perforator with a diameter of 5mm by an alcohol lamp on an aseptic super clean bench by adopting a hypha growth rate method, cooling to room temperature, and perforating various activated pathogenic bacteria by the perforator; inoculating the fungus cake to the center of the cooled flat plate with the drug culture medium by using a No. 11 surgical blade, covering the plate with a dish cover, placing the plate in an incubator at 25 ℃ in the dark for culturing, wherein the three are parallel, and taking an average value when counting results.
(4) Investigation and calculation
And (4) inspecting the growth condition of the hyphae of the pathogenic bacteria according to the growth condition of the colonies in the blank control culture dish, and measuring the diameter of each treated colony by a cross method after the colonies in the blank control culture dish fully grow.
The hypha growth inhibition rate calculation formula is as follows:
the hypha growth inhibition ratio (%) × 100% (control colony growth diameter-agent-treated colony growth diameter)/(control colony growth diameter-7)).
In vitro bactericidal activity the results of the in-house bactericidal activity measurements are shown in table 2. At a concentration of 50mg/L, most compounds showed good in vitro bacteriostatic activity against the 7 tested pathogens. Part of the compounds have the highest overall activity on sclerotium napellus (SS) and have the inhibiting activity equivalent to that of the control medicaments of azoxystrobin and trifloxystrobin.
TABLE 2 in vitro fungicidal Activity of part of the target Compounds
Figure BDA0001248347480000141
Figure BDA0001248347480000151
Sclerotinia sclerotiorum (Lib.) de bark; BC (Botrytis cinerea); PI ═ Phytophthora infestans (Mont.) De Bary); pythium aphanidermatum (Pythium aphanidermatum); rhizoctonia solani (Rhizoctonia solani); PG ═ Pyricularia grisea (Pyricularia grisea); colletotrichum gloeosporioides (colletotrichum orbicular. (Berk. & ent.))
Determination of EC of target Compounds on Sclerotinia sclerotiorum50In this case, the experimental method was also the colony diameter method. Setting six concentration gradients, calculating the inhibition rate of the target compound on sclerotinia rot of rape under each concentration, and obtaining the EC of the target compound through statistical calculation of IBM SPSSStatics 20 software50The value is obtained. The measurement results are shown in Table 3. As can be seen, the compound I in the general formula is equivalent to azoxystrobin and trifloxystrobin in a biological activity test, and the EC of part of compounds on sclerotium rolfsii50Is better than the similar commercialized azoxystrobin. Due to the positive characteristics of the imido phenylacetic acid ester compound, the imido phenylacetic acid ester compound can powerfully protect crops, horticultural plants, fruits and vegetables and the like, and has very good prevention and treatment effects on diseases caused by germs.
TABLE 3 EC of part of the Compounds on sclerotium of Brassica napus50
Numbering EC50(μg·mL-1) 95% confidence Limit
1 0.474 0.177-0.915
4 0.853 0.398-1.510
7 2.278 1.293-3.874
29 3.253 1.235-8.896
30 1.441 0.754-2.478
31 1.055 0.560-1.750
Azoxystrobin 0.791 0.445-1.440
Example 4: preparation of Compound 3 wettable powder
The compound 3 wettable powder consists of the following substances in percentage by mass:
Figure BDA0001248347480000161
the compound and the components are fully mixed and crushed by an ultrafine crusher to obtain a 50 percent wettable powder product.
Example 5: preparation of Compound 33 suspending agent
The compound 33 suspending agent consists of the following substances in percentage by mass:
Figure BDA0001248347480000162
Figure BDA0001248347480000171
compound 33 and the components were mixed thoroughly to give a suspension product of 35% compound 33.
Example 6: preparation of Compound 56 aqueous Dispersion
The compound 56 water dispersant comprises the following substances in percentage by mass:
Figure BDA0001248347480000172
the compound 56 and the components are fully mixed and crushed, and then added with water to be kneaded, and then the mixture is added into a granulator with a 10-100 mesh screen to be granulated, and then the mixture is dried and screened.
Example 7: preparation of compound 35 and pyraclostrobin composition
The compound 35 and the pyraclostrobin composition consist of the following substances in percentage by mass:
Figure BDA0001248347480000173
and fully mixing the compound 35, the pyraclostrobin and the components to obtain the composition of the compound 35 and the pyraclostrobin.

Claims (8)

1. An imido phenylacetic acid ester compound is characterized in that the imido phenylacetic acid ester compound is a compound shown in a formula I,
Figure FDA0002379502880000011
in the formula I, R1、R2、R3、R4And R5Respectively is hydrogen, halogen, nitro, cyano, hydroxyl, amino, acetamido, methyl ketone, C1-C12Alkyl, halo C1-C12Alkyl radical, C1-C12Alkoxy radical, C1-C12Alkylthio radical, C1-C12Alkanesulfonyl group, C1-C12Alkylcarbonyl, benzyloxy, phenoxy or pyridyloxy.
2. The method for preparing imido phenylacetic acid esters according to claim 1, which comprises the steps of:
1) diethyl malonate reacts with magnesium chloride to obtain diethyl carboxylic acid methyl magnesium chloride, chloronicotinic acid reacts with thionyl chloride to obtain chloronicotinoyl chloride, the diethyl carboxylic acid methyl magnesium chloride reacts with the chloronicotinoyl chloride to obtain a compound shown in a structural formula 1, the compound shown in the structural formula 1 is decomposed by a ketone formula to obtain a compound shown in a structural formula 2, and then the compound is reacted with polysubstituted phenol to obtain a compound shown in an intermediate 1;
2) preparing a compound shown in a structural formula 4 by taking N-hydroxyphthalimide and a compound shown in a structural formula 3 as raw materials, and then reacting the compound with hydrazine hydrate to obtain a compound shown in an intermediate 2;
3) and reacting the intermediate 1 with the intermediate 2 to obtain the compound shown in the formula I.
Figure FDA0002379502880000012
Figure FDA0002379502880000021
3. The use of an iminophenylacetic acid ester compound of claim 1 in the preparation of a fungicide.
4. The use as claimed in claim 3, wherein the active ingredient of the bactericide is the iminophenylacetic acid ester compound as claimed in claim 1.
5. The wettable bactericide powder is characterized by comprising the following substances in percentage by mass: 40% of the imidophenylacetic acid ester compound of claim 1, 2% of sodium dodecyl sulfate, 3% of sodium lignosulfonate, 5% of naphthalene sulfonic acid formaldehyde condensate and 50% of light calcium carbonate.
6. The bactericide suspending agent is characterized by comprising the following substances in percentage by mass: 50% of the iminophenyl acetic acid ester compounds described in claim 1, 10% of ethylene glycol, 6% of nonylphenol polyethylene glycol ether, 10% of sodium lignosulfonate, 1% of carboxymethyl cellulose, 0.2% of 37% by mass aqueous formaldehyde solution, 0.8% of 75% by mass aqueous silicone oil emulsion and 22% of water.
7. The bactericide water dispersible granule is characterized by comprising the following substances in percentage by mass: 45% of the iminophenylacetic acid ester compounds of claim 1, 12% of naphthalenesulfonic acid-formaldehyde condensate, 8% of sodium N-methyl-N-oleoyl-taurate, 2% of polyvinylpyrrolidone and 3% of kaolin.
8. The bactericide composition is characterized by comprising the following substances in percentage by mass: 20% of the imido phenylacetic acid ester compound of claim 1, 20% of pyraclostrobin, 20% of a dispersing agent, 0-1% of organic bentonite, 1-5% of polyethylene glycol (PEG) 2000 and 34% -39% of water.
CN201710160407.4A 2017-03-17 2017-03-17 High-activity imido phenylacetate compound and preparation method and application thereof Expired - Fee Related CN106946770B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710160407.4A CN106946770B (en) 2017-03-17 2017-03-17 High-activity imido phenylacetate compound and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710160407.4A CN106946770B (en) 2017-03-17 2017-03-17 High-activity imido phenylacetate compound and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN106946770A CN106946770A (en) 2017-07-14
CN106946770B true CN106946770B (en) 2020-05-05

Family

ID=59473184

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710160407.4A Expired - Fee Related CN106946770B (en) 2017-03-17 2017-03-17 High-activity imido phenylacetate compound and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN106946770B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108892636A (en) * 2018-06-25 2018-11-27 华中农业大学 A kind of benzyl carboxylate ester type compound and its purposes for preventing and treating farm crop fungus disease
US20230357152A1 (en) * 2020-08-11 2023-11-09 Basf Se Use of strobilurin type compounds for combating phytopathogenic fungi containing an amino acid substitution f129l in the mitochondrial cytochrome b protein conferring resistance to qo inhibitors viii
EP3970494A1 (en) * 2020-09-21 2022-03-23 Basf Se Use of strobilurin type compounds for combating phytopathogenic fungi containing an amino acid substitution f129l in the mitochondrial cytochrome b protein conferring resistance to qo inhibitors viii

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194662A (en) * 1990-06-27 1993-03-16 Basf Aktiengesellschaft O-benzyloxime ethers and crop protection agents containing these compounds
WO1999011129A1 (en) * 1997-09-04 1999-03-11 E.I. Du Pont De Nemours And Company Enantiomerically enriched compositions and their pesticidal use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194662A (en) * 1990-06-27 1993-03-16 Basf Aktiengesellschaft O-benzyloxime ethers and crop protection agents containing these compounds
WO1999011129A1 (en) * 1997-09-04 1999-03-11 E.I. Du Pont De Nemours And Company Enantiomerically enriched compositions and their pesticidal use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
取代苯氧基-3-乙酰吡啶类中间体的合成;万川等;《化学试剂》;20131015;第35卷(第10期);871-872页 1.2 合成部分 *

Also Published As

Publication number Publication date
CN106946770A (en) 2017-07-14

Similar Documents

Publication Publication Date Title
CN106946770B (en) High-activity imido phenylacetate compound and preparation method and application thereof
CN103664808B (en) A kind of aryl 3-triazole compounds containing chlorocyclopropane and preparation method thereof and application
CN107711855B (en) Application of camelinine A derivative in preparation of medicines for preventing and treating or resisting plant diseases
AU2020424232B2 (en) 2-(1,2,4-triazolyl)benzoyl arylamine active compound for inhibiting wheat take-all pathogen
CN109810062B (en) Phenylimidazole derivative, synthesis method thereof and application of phenylimidazole derivative in pesticide
CN111642504A (en) Quinoline 4-hydroxypyridine formate compound and application thereof in preventing and treating rice blast germs
EA004574B1 (en) Oxime o-ether compounds and fungicides for agricultural and horticultural use
CN115925576B (en) Bisamide compound containing sevoflurane isopropyl, and preparation method and application thereof
CN114213311B (en) Substituted benzaldehyde oxime ester compound and preparation method and application thereof
CN104370891B (en) A kind of 5-(butylene lactone-3-ethylidene)-2-aminooimidazole quinoline ketone compounds, preparation method and applications
CN103724292B (en) N-alcoxyl (sulphur) alkyl Benzheterocyclic derivatives and uses thereof
CN107721956B (en) Benzobutyrolactone derivative, synthesis method and application thereof in preparing bactericide
CN107629012B (en) Phenazine-1-carboxylic acid bisamide compound and application thereof
CN105924397B (en) A kind of formic acid esters pyrazole compound of 1,5 diaryl 3, Preparation method and use
CN110862361A (en) High-efficiency low-toxicity pollution-free bactericidal agricultural new compound and composition thereof
CN107494553A (en) Disinfectant use in agriculture and purposes derived from a kind of gallic acid
CN110437099B (en) Aromatic hydrazide compound and preparation method and application thereof
CN103864662A (en) Pyrrolidine diones-containing methoxy methyl acrylate compound, preparation method and application thereof
KR100229440B1 (en) Novel propenoic ester and amide derivatives having a fluorovinyl group
CN109503612B (en) Structure modifier of 8-methoxypsoralen and preparation method and application thereof
CN107445933B (en) 3-coumarin formic acid compound and application thereof in preparation of phytopathogen antibacterial agent
CN111499587A (en) Methoxy acrylate compound containing 1,2, 4-triazole Schiff base and preparation method and application thereof
CN114957124B (en) 3- (trifluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof
CN110463704B (en) Application of 1-adamantane carboxylic acid-2- (substituted benzoyl oxy) ethyl ester compound as bactericide
CN111763231B (en) Synthesis method and application of triphenyl phosphonium cation-containing bactericidal and acaricidal compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20200505

Termination date: 20210317

CF01 Termination of patent right due to non-payment of annual fee